This article is more than 5 years old. Information may no longer be current.
AMO, Quest Vision announce licensing agreement for accommodating IOL
SAN DIEGO, Calif. — Advanced Medical Optics announced a 1-year research and evaluation licensing agreement with Quest Vision Technologies to develop accommodating IOL designs, according to AMO officials.
Two Quest Vision accommodating IOL designs, FocusIOL and FlexOptic, are being developed for the treatment of presbyopia. “Under the agreement, AMO will have access to a number of issued and pending patents for various design approaches that encompass both axial movement and shape changing technology,” according to an AMO press statement released here at the American Society of Cataract and Refractive Surgery.
Under the terms of the agreement, AMO will own a minority interest in Quest Vision, with an option to purchase the company after 1 year. No other terms were disclosed, according to AMO.